Campitelli, Maura
 Distribuzione geografica
Continente #
NA - Nord America 945
AS - Asia 897
EU - Europa 542
SA - Sud America 181
AF - Africa 41
OC - Oceania 2
Totale 2.608
Nazione #
US - Stati Uniti d'America 899
SG - Singapore 343
CN - Cina 170
VN - Vietnam 169
BR - Brasile 154
IT - Italia 114
SE - Svezia 105
DE - Germania 92
IN - India 64
FR - Francia 59
GB - Regno Unito 41
IE - Irlanda 26
CA - Canada 21
FI - Finlandia 21
JP - Giappone 21
BD - Bangladesh 20
HK - Hong Kong 19
MX - Messico 19
ID - Indonesia 17
RU - Federazione Russa 16
CI - Costa d'Avorio 13
NL - Olanda 12
IQ - Iraq 11
AR - Argentina 10
UA - Ucraina 9
BE - Belgio 8
ES - Italia 8
KR - Corea 8
TR - Turchia 8
ZA - Sudafrica 8
AT - Austria 6
CL - Cile 6
EC - Ecuador 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
IR - Iran 5
PK - Pakistan 5
BH - Bahrain 4
KE - Kenya 4
MA - Marocco 4
MT - Malta 4
PH - Filippine 4
PL - Polonia 4
CO - Colombia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
LT - Lituania 3
SN - Senegal 3
EG - Egitto 2
ET - Etiopia 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BY - Bielorussia 1
CH - Svizzera 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 2.608
Città #
Singapore 188
San Jose 107
Ashburn 95
Chandler 94
Beijing 66
Ho Chi Minh City 58
Hanoi 40
Los Angeles 37
The Dalles 37
New York 36
Rome 31
Dublin 26
Munich 25
Hefei 23
Milan 23
Lauterbourg 22
Frankfurt am Main 21
Hyderabad 21
Tokyo 21
St Louis 19
Hong Kong 18
Jacksonville 16
São Paulo 16
Jakarta 15
Abidjan 13
Ann Arbor 13
San Mateo 13
Da Nang 12
Boston 11
Bremen 11
Helsinki 11
Brooklyn 10
Moscow 10
Orem 10
Princeton 10
London 9
Wilmington 9
Dallas 8
Montreal 8
Rio de Janeiro 8
Seoul 8
Brussels 7
Chicago 7
Council Bluffs 7
Kent 7
Atlanta 6
Buffalo 6
Fairfield 6
Hải Dương 6
Marseille 6
Phoenix 6
Chennai 5
City of London 5
Dhaka 5
Guangzhou 5
Lappeenranta 5
Mexico City 5
Amsterdam 4
Augusta 4
Baghdad 4
Boardman 4
Bắc Ninh 4
Cattolica 4
Dearborn 4
Denver 4
Düsseldorf 4
Falkenstein 4
Johannesburg 4
Nairobi 4
Nanjing 4
Nuremberg 4
Santa Clara 4
Toronto 4
Turku 4
Washington 4
Addlestone 3
Almaty 3
Amman 3
Antalya 3
Belo Horizonte 3
Bengaluru 3
Bismarck 3
Biên Hòa 3
Blida 3
Cambridge 3
Curitiba 3
Dakar 3
Dubai 3
Haiphong 3
Hortolândia 3
Houston 3
Istanbul 3
Kish 3
Nanchang 3
Ninh Bình 3
North Bergen 3
Ottawa 3
Paola 3
Poplar 3
Querétaro 3
Totale 1.470
Nome #
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 189
The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study 147
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 145
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 139
EROS study: Evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis 138
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 137
Recurrent Endometrial Cancer: Which Is the Best Treatment? Systematic Review of the Literature 136
Standardized data collection to build prediction models in oncology: A prototype for rectal cancer 132
Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer 127
DW-MRI predictive factors for radiation-induced vaginal stenosis in patients with cervical cancer 127
Low Tesla magnetic resonance guided radiotherapy for locally advanced cervical cancer: first clinical experience 124
Machine-learning prediction of treatment response to stereotactic body radiation therapy in oligometastatic gynecological cancer: A multi-institutional study 118
Real-world outcomes of PARP inhibitor maintenance in advanced ovarian cancer: a focus on disease patterns and treatment modalities at recurrence 116
EROS 2.0 study: evaluation of two interventional radiotherapy (brachytherapy) schedules for endometrial cancer: a comparison of late vaginal toxicity rates 110
Efficacy and Safety of Stereotactic Body Radiation Therapy in Oligometastatic Uterine Cancer (MITO-RT2/RAD): A Large, Real-World Study in Collaboration With Italian Association of Radiation Oncology, Multicenter Italian Trials in Ovarian Cancer, and Mario Negri Gynecologic Oncology Group Groups 110
REPeated mAgnetic resonance Image-guided stereotactic body Radiotherapy (MRIg-reSBRT) for oligometastatic patients: REPAIR, a mono-institutional retrospective study 109
The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study 105
Hybrid MRI guided radiotherapy in locally advanced cervical cancer: Case report of an innovative personalized therapeutic approach 100
Locoregional pain treatment. Troubles and prospectives: antalgic radiotherapy 99
Neoadjuvant Chemoradiotherapy With Simultaneous Integrated Boost in Locally Advanced Cervical Cancer: Long Term Results of a Single-Center Experience 93
Stereotactic Body Radiation Therapy for Oligoprogressive Ovarian Cancer Patients Treated During Poly(ADP-Ribose)-Polymerase Inhibitor Maintenance: Efficacy and Adverse Events From the Epimetheo Retrospective Study 45
Treatment of Oligometastatic Parenchymal Lesions in Ovarian Cancer With Stereotactic Ablative Radiation Therapy: A Multicenter Prospective Phase 2 Trial (MITO RT3/RAD) 38
Stereotactic body radiotherapy and poly (ADP-ribose) polymerase inhibitors in ovarian cancer: a knowledge and attitudes survey in collaboration with the Italian Association of Radiation Oncology (AIRO) and Multicenter Italian Trials in Ovarian Cancer (MITO) groups 31
Stereotactic Ablative Radiation Therapy for Oligometastatic Ovarian Cancer Lymph Node Disease: The MITO-RT3/RAD Phase II Trial 28
The Impact of HAPPY (Humanity Assurance Protocol in Interventional Radiotherapy) on the Psychological Well-being of Gynecological Cancer Patients 1
Totale 2.644
Categoria #
all - tutte 10.385
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.385


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022115 14 3 2 14 4 2 0 25 7 7 21 16
2022/2023314 29 32 21 54 15 34 20 15 36 44 10 4
2023/2024183 6 46 19 16 9 26 13 4 2 4 16 22
2024/2025467 7 7 22 12 43 9 28 17 62 60 112 88
2025/20261.420 160 50 71 192 211 92 270 87 109 102 51 25
Totale 2.644